Delivery Order SPE2DB25D9321-SPE2DB25FQWLZ
Award Date 1/23/25
Potential Completion Date 2/13/25
Potential Value $9.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,736.39 contract is for the supply of OCALIVA 10 MG TABLET 30S, a specialized pharmaceutical product. The contract has an ultimate completion date of December 19, 2024. DMS Pharmaceutical Group has a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,880.91 order is for the supply of OCALIVA 10 mg tablets to support the recurring pharmaceutical needs of military health facilities. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, that allows the agency to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,751.19 contract is for the delivery of 4566562322 - OCALIVA 10 MG TABLET 30S, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers. DMS Pharmaceutical Group holds a $499,999,999 Indefinite...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $9,736.39, is for the delivery of 4567552547 - OCALIVA 10 MG TABLET 30S, a specialized pharmaceutical product. The contract has an ultimate completion date of March 26, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $26,251.35 contract is for the supply of OCALIVA 10 MG TABLET 30S, with a period of performance through September 27, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The $8,751.19 contract is for the supply of OCALIVA 10 MG TABLET 30S, a branded pharmaceutical product. The delivery order is part of a larger, single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $38,952.60 contract is for the supply of OCALIVA 5 MG TABLET 30S, a specialized pharmaceutical product, with a period of performance through March 19, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $9,736.39 from the Defense Logistics Agency (DLA). The award covers the delivery of OCALIVA 10 MG TABLET 30S, a specialized pharmaceutical product, with an ultimate completion date of March 28, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $9,738.15 contract is for the supply of OCALIVA 5 MG TABLET 30S, a specialized pharmaceutical product. The award is not associated with a set-aside program. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, worth up to $17,761.84, is for the delivery of a specific pharmaceutical product, OCALIVA 10 MG TABLET 30S. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue...